Regulatory Updates
🇺🇸 FDA Page 19FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 217–228 of 382 articles
FDA Device Guidance Agenda: Key Regulatory Updates for 2026
FDA · 3 min
Dr. Sarah MitchellLunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy
Parkinson's disease · 2 min
Dr. Sarah MitchellMannKind's Pediatric Expansion: A Game Changer for Afrezza Sales
FDA · pediatric diabetes · 4 min
Dr. Sarah MitchellReplimune's Third Attempt at Cancer Drug Approval: Insights from FDA Talks
FDA · cancer · 3 min
Dr. Sarah MitchellRegulatory Actions in May 2026: Key Updates for Pharma
2 min
Dr. Sarah MitchellAI and Brain Organoids Combat Parkinson's and Rare Epilepsy
Parkinson's disease · 3 min
Dr. Sarah MitchellZydus Therapeutics' Saroglitazar Receives FDA Priority Review
FDA · 3 min
Dr. Sarah MitchellPharmTech’s Regulatory Roundup for May 2026: Drug Approvals
3 min
Dr. Sarah MitchellBizengri Receives FDA National Priority Nod for Rare Bile Duct Cancer
FDA · rare bile duct cancer · 2 min
Dr. Sarah MitchellFDA Commissioner Resignation and Its Impact on Drug Approvals
FDA · 3 min
Dr. Sarah MitchellStates Confront Medical Chatbots Oversight Amid FDA Inaction
FDA · 3 min
Dr. Sarah MitchellAI Breast Cancer Risk Prediction Tool Gains FDA Approval
FDA · oncology · 3 min
Dr. Sarah MitchellExplore intelligence